Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin
Reusch, J., Stewart, M. W., Perkins, C. M., Cirkel, D. T., Ye, J., Perry, C. R., Reinhardt, R. R., Bode, B. W.
Published in Diabetes, obesity & metabolism (01.12.2014)
Published in Diabetes, obesity & metabolism (01.12.2014)
Get full text
Journal Article
Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes
Stewart, M. W., Cirkel, D. T., Furuseth, K., Donaldson, J., Biswas, N., Starkie, M. G., Phenekos, C., Hamann, A.
Published in Diabetic medicine (01.10.2006)
Published in Diabetic medicine (01.10.2006)
Get full text
Journal Article
A phase II study of oral eniluracil/fluorouracil in patients with anthracycline-refractory or anthracycline- and taxane-refractory advanced breast cancer
Skovsgaard, T., Davidson, N. G. P., Piccart, M. J., Richel, D. J., Bonneterre, J., Cirkel, D.T., Barton, C. M., Knight, S.
Published in Annals of oncology (01.09.2001)
Published in Annals of oncology (01.09.2001)
Get full text
Journal Article
Low-Dose Oral Fluorouracil With Eniluracil as First-Line Chemotherapy Against Advanced Breast Cancer: A Phase II Study
Smith, I E, Johnston, S R, O'Brien, M E, Hickish, T F, de Boer, R H, Norton, A, Cirkel, D T, Barton, C M
Published in Journal of clinical oncology (01.06.2000)
Published in Journal of clinical oncology (01.06.2000)
Get full text
Journal Article